期刊文献+

黄芪总苷和三七总皂苷配伍对脑缺血再灌注后MMP-9和TIMP-1表达的影响 被引量:30

Influence of astragalosides and Panax notoginseng saponins compatibility on MMP-9 and TIMP-1 after cerebral ischemia-reperfusion in mice
原文传递
导出
摘要 目的:研究黄芪总苷(AST)和三七总皂苷(PNS)配伍对小鼠脑缺血再灌注后脑组织基质金属蛋白酶-9(matrix met-alloproteinase-9,MMP-9)与组织基质金属蛋白酶抑制物-1(tissue inhibitor of meta11oproteinase-1,TIMP-1)表达的影响,探讨其抗缺血性脑损伤的保护机制。方法:C57BL/6N小鼠随机分成假手术组、模型组、AST和PNS配伍高、中、低剂量组、AST单用组、PNS单用组及依达拉奉组,连续给药4 d后结扎双侧颈总动脉20 min,再灌注24 h,建立脑缺血再灌注模型,用HE染色检测海马区病理形态,用Western-blot法检测MMP-9与TIMP-1蛋白在脑组织的表达。结果:各药物组神经元存活率显著高于模型组(P<0.01),以配伍中剂量组作用显著,析因分析表明AST(110 mg.kg-1)与PNS(115 mg.kg-1)配伍具有协同的交互作用(P<0.01)。各药物组脑组织MMP-9蛋白表达显著低于模型组(P<0.01或P<0.05),而TIMP-1的表达显著高于模型组(P<0.05或P<0.01),且以配伍中剂量组作用显著,两药配伍均具有叠加的交互作用(P<0.05)。结论:AST110 mg.kg-1与PNS 115 mg.kg-1配伍具有协同抗脑缺血再灌注损伤的作用,其机制可能与调节缺血脑组织MMP-9,TIMP-1的蛋白表达有关。 Objective: To investigate the effect of astragalosides(AST) and Panax notoginseng saponins(PNS) compatibility on the expression of matrix metalloproteinases-9(MMP-9) and tissue inhibitor of meta11oproteinase-1(TIMP-1) after cerebral ischemia/reperfusion(I/R) injury in mice,to probe into its anti-ischemic brain injury protection mechanism.Method:C57BL/6N mice were randomly divided into sham-operation group,model group,AST and PNS compatibility of high,medium and low-dose group,AST group,PNS group and edaravone group.Cerebral ischemia-reperfusion injury were prepared by bilateral common carotid artery ligation for 20 min followed by 24 hours reperfusion after administration for 4 days.Pathomorphism was detected with HE staining and the expression of MMP-9 and TIMP-1 protein in brain was detected by western-blot.Result: The neuronal survival rate in the drug groups was significantly higher than the control group(P0.01),and the effect of the-middle dose compatibility group was more obvious.Factorial analysis manifested that AST110 mg·kg-1 and PNS115 mg·kg-1 compatibility had a synergistic interaction(P0.01).The expression of MMP-9 protein in the drug groups was lower than the model group significantly(P0.01 or P0.05),but the expression of TIMP-1 protein was higher than the model group significantly(P 0.01 or P0.05),and the effect of the-middle dose compatibility group was more obvious,the two drugs had the stacking interaction(P0.05).Conclusion:AST110 mg·kg-1 and PNS115 mg·kg-1 compatibility has a synergistic effect against ischemia-reperfusion injury in mice by accommodating MMP-9/TIMP-1 probably.
出处 《中国中药杂志》 CAS CSCD 北大核心 2010年第16期2187-2191,共5页 China Journal of Chinese Materia Medica
基金 湖南省教育厅重点项目(08A050)
关键词 黄芪总苷 三七总皂苷 脑缺血再灌注 基质金属蛋白酶-9 组织基质金属蛋白酶抑制物-1 cerebral ischcmia reperfusion damage astragalosides Panax notoginseng saponins matrix metalloproteinases-9 tissue inhibitor of meta11oproteinase-1
  • 相关文献

参考文献17

  • 1Yang G, Kitagawa K, Matsushita K,et al. C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia[ J]. Brain Res, 1997,28,752(1/2) :209.
  • 2Wellons J C, Sheng H, Laskowitz DT, et al. A comparison of strain-related sueceptibility in two routine recovery models of global cerebral iscbemia[ J]. Brain Res,2000,868( 1 ):14.
  • 3Gasche Y, Copin J C, Sugawara T, et al. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia[ J ]. J Cereb Blood Flow Metab,2001,21 (12):1393.
  • 4Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia[J]. J Neurosci ,2001,21 (19) :7724.
  • 5Krizanac-Bengez L, Hossain M, Fazio V, et al. Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines[J]. Am J Physiol Cell Physiol,2006,291 (4) :C740.
  • 6Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitiors of metalloproteinases: structure, function, and biochemistry [J]. CiRc Res ,2003,92(8) :827.
  • 7Groves M D, Puduvalli V K, Hess K R, et al. Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme [J]. J Clin Oncol,2002,20(5) :1353.
  • 8Bond M, Fabunmi R P, Baker A H, et al. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappaB[J]. FEBSLett,1998,435(1):29.
  • 9Van den Steen P E, Proost P, Wuyts A, et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF4, and GRO-alpha and leaves RANTES and MCP-2 intact [ J ]. Blood, 2000,96 ( 8 ) : 2673.
  • 10Han Y P, Tuan T L, Hughes M, et al. Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin [ J ]. J Biol Chem,2001,276 (25) :22341.

二级参考文献26

  • 1闵小芬,李卫平,王绍斌,何婷,尹艳艳,明亮.黄芪提取物对局灶性脑缺血再灌注损伤的抗氧化及线粒体保护作用[J].中国药理学通报,2005,21(2):216-219. 被引量:41
  • 2韩金安.三七总皂甙对中枢神经损伤时氧自由基病理作用的影响[J].中国药理学通报,1996,12(6):487-489. 被引量:21
  • 3包仕尧,傅琦,张志琳,刘春风.白细胞在实验性脑缺血中作用及中药川芎嗪和丹皮酚对其影响的研究[J].中国神经精神疾病杂志,1997,23(1):7-10. 被引量:33
  • 4Koizumi JI, Yoshida Y, Nakazawa T et al.A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemia area[J]. Stroke,1986,8(1):1-8.
  • 5Longa EZ, Weinstein PR, Carlson S. Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
  • 6Piantadosi CA, Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat[J]. Stroke,1996,27(2):327-32.
  • 7Chan PH. Role of oxidants in ischemic brain damage[J].Stroke,1996,27(6):1124-9.
  • 8Barber DA, Hamis SR.oxygen free radicals and antioxidants:A review[J].Am Pharm,1994,34(9):26-35.
  • 9Renolleau S, Aggoun-Zouaoui D, Ben-Ari Y. A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat: Morphological changes indicative of apoptosis[J].Stroke,1998,29(7):1451-61.
  • 10Fiskum G, Murphy AN, Beal MF. Mitochondrial in neurodegeneration:Acute ischemia and chronic neurodegenerative diseases[J].J Cereb Blood Flow Meta,1999,19(4):351-69.

共引文献76

同被引文献457

引证文献30

二级引证文献485

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部